GlassScriptPhysician profile
Sarah B Scott
NPI 1225247760
$755.26
in general payments reported to CMS, 2019-2025
14 companies · $19.07 in 2025
The $19.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.75 · 2021: $438 · 2022: $188 · 2024: $35.56 · 2025: $19.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.83 | 2020-2022 | |
| Hologic Sales and Service, LLC | $117.81 | 2020-2021 | |
| Coopersurgical, INC. | $83.79 | 2021-2022 | |
| Organon LLC | $60.66 | 2021 | |
| Mylan Pharmaceuticals INC. | $34.39 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.87 | 2020-2021 | |
| Novo Nordisk INC | $28.89 | 2021-2022 | |
| Therapeuticsmd, INC. | $24.75 | 2021 | |
| Tris Pharma INC | $19.13 | 2021 | |
| Lilly USA, LLC | $19.07 | 2025 | Zepbound |
| Array Biopharma INC | $18.17 | 2024 | Tukysa, Mektovi, Braftovi |
| Ethicon US, LLC | $17.91 | 2022 | |
| Exeltis, USA INC. | $17.60 | 2021 | |
| Pfizer INC. | $17.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.